Willem Scholten

Willem Scholten

Auto-generated profile, based on publicly available information

Willem Scholten

Willem Scholten Consultancy, Wielsekade 64, 3411 AD Lopik, The Netherlands https://twitter.com/WKScholten

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2018 in BMC International Health and Human Rights
Verified
Journal Article
Open access
PDF file
NTNguyen-Toan Tran
Nguyen-Toan Tran
SBStéphanie Baggio
Stéphanie Baggio
ADAngela Dawson
Angela Dawson
ÉOÉamonn O’mOore
Éamonn O’mOore
BWBrie Williams
Brie Williams
HWHans Wolff
Hans Wolff
Words matter when describing people involved in the criminal justice system because language can have a significant impact upon health, wellbeing, and access to health information and services. However, terminology used in policies, programs, and research publications is often derogatory, stigmatizing, and dehumanizing. In response, health experts from Europe, the United States, and Australia recommend that healthcare professionals, researchers, and policy makers working with people in detention follow key principles that foster constructive and humanizing language. These principles include: engage people and respect their preferences; use stigma-free and accurate language; prioritize individuals over their characteristics; and cultivate self-awareness. The article offers examples of problematic terms to be avoided because they do not convey respect for incarcerated people and propose preferred wording which requires contextualization to local language, culture, and environment. The use of respectful and appropriate language is a cornerstone of reducing harm and suffering when working with people involved in the criminal justice system; the use of stigmatizing and dehumanizing language must therefore come to an end.

1 August 2010 in Journal of Pain & Palliative Care Pharmacotherapy
Verified
Journal Article
Closed access
PDF file
EKEric L. Krakauer
Eric L. Krakauer
RWRoberto Wenk
Roberto Wenk
RBRosa Buitrago
Rosa Buitrago
PJPhilip Jenkins
Philip Jenkins
WSWillem Scholten
Willem Scholten
Strong opioids such as morphine are rarely accessible in low- and middle-income countries, even for patients with the most severe pain. The three cases reported here from three diverse countries provide examples of the terrible and unnecessary suffering that occurs everyday when this essential, inexpensive, and safe medication is not adequately accessible by patients in pain. The reasons for this lack of accessibility are explored, and ways to resolve the problem are proposed.

1 July 2007 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
WSWillem Scholten
Willem Scholten
HNHelena Nygren-Krug
Helena Nygren-Krug
HZHoward A. Zucker
Howard A. Zucker

1 June 2015 in Acta Anaesthesiologica Taiwanica
Verified
Journal Article
Closed access
JPJoseph V. Pergolizzi
Joseph V. Pergolizzi
WSWillem Scholten
Willem Scholten
KSKevin J. Smith
Kevin J. Smith
JLJames Leighton-Scott
James Leighton-Scott
JWJenna C. Willis
Jenna C. Willis
JHJack E. Henningfield
Jack E. Henningfield

1 December 2017 in Public Health
Verified
Journal Article
Closed access
WSW. Scholten
W. Scholten
OSO. Simon
O. Simon
IMI. Maremmani
I. Maremmani
CWC. Wells
C. Wells
JKJ.F. Kelly
J.F. Kelly
LRL. Radbruch
L. Radbruch

22 November 2019 in Journal of Pain & Palliative Care Pharmacotherapy
Verified
Journal Article
Closed access
WSWillem Scholten
Willem Scholten
ACAnn-Eva Christensen
Ann-Eva Christensen
AOAnne Estrup Olesen
Anne Estrup Olesen
ADAsbjørn M. Drewes
Asbjørn M. Drewes
Many countries around the world have a very low per capita consumption of opioid analgesics, which is probably related to absence or inadequate management of moderate and severe pain for large parts of their populations. We conducted a longitudinal observational study with opioid analgesic consumption data for all countries from 2000–2015, to assess 2015 per capita consumption data for strong opioid analgesics and to investigate the hypothesis that inequality decreased over the years 2000–2015. We based our study on the official statistics kept by the International Narcotics Control Board, built on data submitted by governments annually. Adequate consumption was defined as the average 2015 opioid analgesic consumption of the 20 most-developed countries, or above. In addition, we defined categories of moderate, low, very low and extremely low consumption, each category differing 0.5 on a logarithmic scale. Consumption was expressed as the AOC Index. The direction of inequality in consumption between different countries’ development levels through the years 2000–2015 was assessed using a mixed effects model. We found that the average consumption of the 20 most-developed countries was 256 ± 208 mg per capita (range 5.9–778) in 2015. In all, 119 countries did not have a moderate or adequate consumption of opioid analgesics. Inequality of adequacy of consumption between low- and highly-developed countries increased from 2000 to 2015. The world needs 1867 tonnes ME for treating pain with opioids analgesics at an adequate level (actual use: 365 tonnes or 19.5% of the global need). We concluded that in 2015, almost 6.5 billion people lived in countries where opioid analgesic consumption was low, very low, or extremely low.